Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR wilt likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves. (C) 2022 by the American College of Cardiology Foundation.
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves
Tarantini, Giuseppe;Nai Fovino, Luca;
2022
Abstract
Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR wilt likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves. (C) 2022 by the American College of Cardiology Foundation.File | Dimensione | Formato | |
---|---|---|---|
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves.pdf
Accesso riservato
Tipologia:
Published (publisher's version)
Licenza:
Accesso privato - non pubblico
Dimensione
3.59 MB
Formato
Adobe PDF
|
3.59 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.